ICY:FRA
Incyte Corp
€95.98
arrow_downward
-1.66%(-1.62) 1D
Okt 14, 8:01:16 AM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ICY...
Buksan
€95.98
Mataas
€95.98
Mababa
€95.98
Mkt. cap
22.71B
Avg. na dami
34.00
Dami
0.00
Mataas nang 52-wk
€115.40
Mababa nang 52-wk
€72.28
Bilang ng mga empleyado
3K
Buksan
€95.98
Mataas
€95.98
Mababa
€95.98
Mkt. cap
22.71B
Avg. na dami
34.00
Dami
0.00
Mataas nang 52-wk
€115.40
Mababa nang 52-wk
€72.28
Bilang ng mga empleyado
3K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Globe and Mail
·
8 oras ang nakalipas
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)
Yahoo Finance
·
1 araw ang nakalipas
Incyte Honors the 2026 MPN Heroes®, Celebrating Champions of the Myeloproliferative Neoplasm (MPN) Community
Investing.com
·
1 araw ang nakalipas
Incyte stock price target maintained at $152 by H.C. Wainwright
TipRanks
·
2 araw ang nakalipas
GEN İlaç Secures Exclusive Rights to Incyte Drugs in Türkiye and Azerbaijan
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Tungkol sa Incyte Corp
CEO-
Mga Empleyado2.84K
Itinatag2002
HeadquartersWilmington, Delaware, Estados Unidos
Sektor-
Websiteincyte.com